Shin Nippon Biomed Lab (2395)

Tokyo
Currency in JPY
1,730.0
-33.0(-1.87%)
Closed
2395 Scorecard
Full Analysis
Quickly burning through cash
Fair Value
Day's Range
1,727.01,761.0
52 wk Range
970.01,897.0
Key Statistics
Edit
Bid/Ask
1,729.00 / 1,736.00
Prev. Close
1,763
Open
1,756
Day's Range
1,727-1,761
52 wk Range
970-1,897
Volume
324.2K
Average Volume (3m)
319.78K
1-Year Change
12.68%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
2395 Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Price Target
2,530.0
Upside
+46.24%
Members' Sentiments
Bearish
Bullish
ProTips
Prominent player in the Life Sciences Tools & Services industry
Show more

Shin Nippon Biomed Lab Company Profile

Shin Nippon Biomedical Laboratories, Ltd., a contract research organization, engages in the transactional research and medipolis businesses in Japan and internationally. It offers non-clinical studies, including single/repeated dose toxicity studies, antigenicity studies, skin sensitization studies, genotoxicity studies, carcinogenicity studies, local irritation studies, inhalation toxicity studies, TK studies, characteristic studies, stability studies, dependence studies, reproductive and developmental toxicity studies, safety pharmacological studies, and pharmacokinetic studies. The company also engages in the investigator brochure preparation support, clinical trial protocol creation support, clinical trial medical institution, investigational drug allocation, clinical trial request/contract, monitoring, quality management, data management, statistical analysis work, comprehensive report creation support, electronic application support, regulatory affairs consulting, and creating informed consent documents support services. In addition, it provides site management organization services for clinical trials; clinical contract research organization services; and translational research services, including research and development of vaccines and therapeutic drugs, antibody drugs, nucleic acid drugs, peptide drugs, gene therapy, and regenerative medicines. Further, the company is involved in the operates geothermal power generation; operates hotel accommodation facilities; and wellbeing businesses, as well as provides cleaning, clerical work, and welfare services. Shin Nippon Biomedical Laboratories, Ltd. was founded in 1957 and is headquartered in Kagoshima, Japan.

Employees
1457
Market
Japan

Compare 2395 to Peers and Sector

Metrics to compare
2395
Peers
Sector
Relationship
P/E Ratio
14.8x16.0x−0.6x
PEG Ratio
−1.46−0.150.00
Price/Book
1.6x1.8x2.6x
Price / LTM Sales
2.4x2.8x3.1x
Upside (Analyst Target)
43.5%29.3%52.8%
Fair Value Upside
Unlock23.9%8.4%Unlock

Analyst Ratings

1 Buy
1 Hold
0 Sell
Ratings:
2 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 2,530.0
(+46.24% Upside)

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 118.71
Dividend Yield
2.84%
Industry Median 0.45%
Annualised payout
50
Paid unevenly
5-Years Growth
-
Growth Streak

Earnings

Latest Release
Feb 05, 2025
EPS / Forecast
45.02 / 21.80
Revenue / Forecast
9.73B / 9.04B
EPS Revisions
Last 90 days

People Also Watch

3,960.0
4626
+0.64%
3,045.0
9025
-0.81%
3,935.0
1980
-0.13%
2,624.5
1942
+0.27%
3,140.0
1663
+1.29%

FAQ

What Is the Shin Nippon Biomed Lab (2395) Stock Price Today?

The Shin Nippon Biomed Lab stock price today is 1,730.00

What Stock Exchange Does Shin Nippon Biomed Lab Trade On?

Shin Nippon Biomed Lab is listed and trades on the Tokyo stock exchange.

What Is the Stock Symbol for Shin Nippon Biomed Lab?

The stock symbol for Shin Nippon Biomed Lab is "2395."

Does Shin Nippon Biomed Lab Pay Dividends? What’s The Current Dividend Yield?

The Shin Nippon Biomed Lab dividend yield is 2.89%.

What Is the Shin Nippon Biomed Lab Market Cap?

As of today, Shin Nippon Biomed Lab market cap is 72.15B.

What is Shin Nippon Biomed Lab Earnings Per Share?

The Shin Nippon Biomed Lab EPS is 118.71.

What Is the Next Shin Nippon Biomed Lab Earnings Date?

Shin Nippon Biomed Lab will release its next earnings report on 11 May 2025.

From a Technical Analysis Perspective, Is 2395 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Buy.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.